Prescription Drug Abuse and Diversion Training Conference
The objective of this course is to provide further education and knowledge of the Pennsylvania drug laws related to the medical field, safety with fentanyl and naloxone, preventing institutional drug diversion, an expert perspective on opioid prescribing, and current drug trends, specifically opioids.
The target audience for this training includes medical professionals, first responders, law enforcement and compliance investigators.
|Prescription Drug Abuse Diversion Training Conference July 23 2021 handout (004) approved.pdf||168.13 KB|
7:30 AM - 8:30 AM Registration - Coffee Service
8:30 AM - 8:45 AM Opening Remarks
Charlie Cichon, NADDI Executive Director
Matt Massaro, NADDI PA State Chapter President
8:45 AM - 9:40 AM Prescription Drug Laws, Prevention of Diversion and Case Study
Matt Massaro, NADDI PA Chapter President
Pennsylvania Attorney General Narcotics Agent
9:40 AM Break
9:50 AM - 10:50 AM Drug Abuse During COVID-19
Dr. Matthew Bouchard
10:50 AM Break
11:00 AM - 12:15 PM Real Life Story of Addiction and the Impact on the Family of a Law
Kevin Simmers, Former Maryland Narcotics Officer
12:15 PM - 1:00 PM Boxed Lunch – Provided by NADDI
1:00 PM - 2:00 PM Controlled Substances Investigations: A Physician’s Perspective
Stephen M. Thomas, MD
2:00 PM Break
2:15 PM - 3:15 PM Rx Diversion: Opioid Abuse – The Scope of the Problem
Dan Zsido, NADDI National Director Education and Training
3:15 PM Break
3:30PM - 4:30 PM Preventing and Investigating Institutional Diversion
PA Office of the Attorney General (Retired)
4:30 PM Closing Remarks
5:00 PM Adjournment
Sherri O’Donald, Controlled Substance Compliance Manager, PA NADDI Vice President, Altoona, PA
Matthew Massaro, Narcotics Agent, PA Office of Attorney General, State College, PA
Edward Cartwright, Retired Narcotics Agent, PA Office of Attorney General, North Huntingdon, PA
Kevin Simmers, Retired Police Officer Hagerstown, MD
Matthew Bouchard, Chairman of Emergency Medicine, UPMC Altoona, Altoona, PA
Stephen Thomas, Medical Expert, Pittsburgh, PA
Dan Zsido, NADDI National Education and Training Director, Seminole, Florida
All individuals in a position to control the content of this education activity including members of the planning committee, speakers, presenters, authors, and/or content reviewers have disclosed all relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.
The following relevant financial relationships were disclosed:
• Edward Cartwright is an employee of Value Drug Company.
No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
In support of improving patient care, this activity has been planned and implemented by the University of Pittsburgh and National Association of Drug Diversion Investigators (NADDI). The University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The maximum number of hours awarded for this Continuing Nursing Education activity is 6.75 contact hours.
This knowledge-based activity provides 6.75 contact hours of continuing pharmacy education credit.
Other Healthcare Professionals
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
- 6.75 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
- 6.75 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 6.75 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 6.75 Attendance
Conference Registration Information
Registration will be completed online
2021 NADDI Pennsylvania Regional Training Conference - NADDI - National Association of Drug Diversion Investigators
Participation by all individuals is encouraged. Advance notification of any special needs will help us provide better service. Please notify us of your needs at least two weeks in advance of the program by calling 814-889-2226.
The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.